Marshall Wace’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Buy |
+232,123
| New | +$2.17M | ﹤0.01% | 1407 |
|
|
2025
Q1 | – | Sell |
-12,624
| Closed | -$167K | – | 2879 |
|
|
2024
Q4 | $167K | Sell |
12,624
-977,280
| -99% | -$12.9M | ﹤0.01% | 2221 |
|
|
2024
Q3 | $19.1M | Sell |
989,904
-840,523
| -46% | -$16.2M | 0.02% | 476 |
|
|
2024
Q2 | $37.6M | Sell |
1,830,427
-201,632
| -10% | -$4.14M | 0.05% | 303 |
|
|
2024
Q1 | $48.4M | Sell |
2,032,059
-69,852
| -3% | -$1.66M | 0.07% | 234 |
|
|
2023
Q4 | $45.4M | Buy |
2,101,911
+1,497,949
| +248% | +$32.4M | 0.08% | 224 |
|
|
2023
Q3 | $8.77M | Buy |
+603,962
| New | +$8.77M | 0.02% | 622 |
|
|
2022
Q3 | – | Sell |
-11,637
| Closed | -$224K | – | 3033 |
|
|
2022
Q2 | $224K | Sell |
11,637
-97,981
| -89% | -$1.89M | ﹤0.01% | 2435 |
|
|
2022
Q1 | $1.91M | Buy |
109,618
+97,981
| +842% | +$1.7M | ﹤0.01% | 1643 |
|
|
2021
Q4 | $254K | Hold |
11,637
| – | – | ﹤0.01% | 2412 |
|
|
2021
Q3 | $222K | Buy |
+11,637
| New | +$222K | ﹤0.01% | 2183 |
|
|
2021
Q1 | – | Sell |
-191,788
| Closed | -$4.27M | – | 2476 |
|
|
2020
Q4 | $4.27M | Buy |
+191,788
| New | +$4.27M | 0.02% | 575 |
|
|
2020
Q2 | – | Sell |
-53,265
| Closed | -$584K | – | 1877 |
|
|
2020
Q1 | $584K | Buy |
+53,265
| New | +$584K | 0.01% | 937 |
|